全球内视镜逆行性胰造影市场：市场规模、份额和趋势分析（2025-2032 年）

预计2025年，全球内视镜逆行性造影（ERCP）设备市场规模将超过19亿美元。预计到2032年，该市场将以5.6%的复合年增长率成长，达到28亿美元以上。

本报告涵盖括约肌切开器、胆道结石取出球囊、胆道结石取出篮、胆道扩张球囊、胆道和胰管支架、胆道结石取出器、ERCP导管导引线和 ERCP 套管。

它量化了销售量、平均售价、市值和成长率，并涵盖了企业市场占有率、市场驱动因素和影响因素、近期併购活动以及技术趋势。分析包括2022年至2024年的历史资料以及至2032年的预测资料。

这反映了医疗专业人员如何接受微创和治疗性 ERCP 技术，以及持续的产品创新，特别是短导丝系统和管腔接近支架，如何提高手术效率和患者疗效。

市场概览

内视镜逆行性造影（ERCP）是一种专门用于诊断和治疗胆道和胰管疾病的内视镜手术。 ERCP结合了内视镜和透视影像技术，可以进行括约肌切开术、取石术和支架置入术等介入性治疗。

过去十年间，随着器材设计和技术的重大进步，ERCP 的角色已从主要作为诊断工具转变为治疗性介入。这种转变扩大了 ERCP 器械的潜在市场，并使该领域成为微创胃肠道治疗的基石。

市场发展主要受已开发地区和新兴地区手术量增加的驱动。胆道阻塞、胆结石和胰臟炎在全球范围内的发病率不断上升，推动了对内视镜逆行性胰胆管造影（ERCP）的需求。此外，人口老化和慢性肝病盛行率的上升也增加了手术频率。

科技创新对提升医师诊疗水准和降低併发症率产生了特别显着的影响。短导丝系统的引入实现了更快的插管速度、更可靠的器械更换以及更有效率的工作流程。如今，许多大型医疗中心已将此类系统视为新的手术标准。

药物释放型支架和管腔贴合支架技术也扩展了 ERCP 的治疗能力，使得在超音波超音波 (EUS) 引导下储存胰臟积液和壁坏死等复杂适应症成为可能。

同时，某些领域，例如ERCP套管，正逐渐被更先进的器械类型（例如括约肌切开器）所取代，这限制了某些类别的成长。儘管存在这些内部变化，预计ERCP设备市场在未来十年仍将持续扩张。

市场驱动因素

括约肌切开刀市场

治疗性内视镜逆行性胰胆管摄影术（ERCP）的兴起是全球市场的主要成长动力。人们越来越重视治疗而非诊断，这推动了对括约肌镜的需求。该领域在ERCP设备市场中占据最大份额，预计将持续影响整体成长至2032年。

括约肌切开刀设计的进步，例如改进的导丝控制和与短导丝系统的兼容性，进一步推动了其应用。随着医院转向使用一次性配件以降低感染风险，预计该类别对整体市场的贡献将进一步增强。

短线系统

短导丝系统的日益普及正在改变ERCP手术的操作方式。这些系统使医生能够更好地控製手术过程，提高手术效率，同时减少插管和器械更换过程中对助手的需求。

虽然短导丝系统比传统的长导丝系统更昂贵，但其临床和操作优势足以证明其成本合理。更短的手术时间提高了手术效率，减少了麻醉暴露，从而加速了其在医院和门诊内视镜检查中的应用。因此，短导丝系统有助于提高平均售价和整体收入。

医生熟悉情况和培训

随着内视镜医师在治疗性ERCP方面经验和训练的积累，该手术的可靠性正在提高。医师技能的提升直接转化为每位医师手术量的增加。医学协会和器械製造商正在扩大培训项目，以提高医师在高级ERCP技术（例如括约肌切开术、支架置入术和体外碎石术）方面的熟练程度。

这一趋势在新兴市场尤其重要，因为在这些市场，获得培训和透视设备的机会越来越多，合格的医疗保健专业人员数量也随之增加，他们可以安全有效地进行 ERCP。

市场限制

套管市场下滑

内视镜逆行性胰胆管摄影术（ERCP）套管正逐渐被括约肌置入术所取代。套管曾是标准的介入工具，但随着更有效率的替代方案的出现，其市占率正在不断下降。因此，近年来套管的销售量停滞不前，平均售价也有所下降。为了保持竞争力，製造商纷纷降低价格，限制了市场整体成长。

预计这种结构性变化将持续到完全消除插管为止，进一步巩固括约肌引导方法的优越性。

ERCP诊断应用减少

近年来，由于对手术风险的担忧，ERCP 的诊断应用已大幅下降。诊断性 ERCP 有发生併发症的风险，虽然风险较小，但仍不容忽视，併发症包括胰臟炎、感染疾病和出血。

磁振造影胰造影(MRCP) 和超音波超音波 (EUS) 等非侵入性替代方法的出现，为临床医生提供了避免这些风险的有效影像选择，从而导致诊断性 ERCP 的数量下降，其用途也转向治疗性适应症。

虽然这种转变促进了括约肌切开器和支架等治疗设备的发展，但也限制了整体手术的扩张，并限制了某些地区的市场成长潜力。

价格竞争

激烈的价格竞争正在抑制ERCP多个细分市场的价值成长。特别是胆道和胰管支架市场，正面临来自韩国和中国低成本製造商日益激烈的竞争。这些製造商透过提供品质相当但价格更低的支架，在欧洲等对成本高度敏感的市场中不断扩大市场份额。

虽然这些压力不如其他内视镜市场（尤其是支架和套管类别）那么严重，但它们仍然对平均售价施加下行压力，并限制收入成长。

目标市场和数据范围

定量范围

市场规模、份额和预测

成长率、销售量、平均售价

定性范围

市场成长趋势与限制因素

竞争对手分析与SWOT分析

併购、公司简介、产品系列

FDA召回和颠覆性技术分析

影响需求的疾病和手术趋势概述

时期

• 基准年：2025年
• 预测：2026-2032年
• 历史资料：2022-2024年

数据来源

对内视镜医师和市场高层的初步调查、监管文件、政府和医院资料、进出口资料库、iData Research内部资料库

方法注记

收入模型为销售量乘以平均售价，透过流程和使用率数据检验，并与区域替代和成长假设进行配对。

目标市场及区隔

• 内视镜逆行性胰造影（ERCP）器材市场－进一步细分如下：

括约肌内寄生虫

胆结石取出球囊

胆管结石取出篮

胆道扩张球囊

胆道和胰管支架

胆结石清除器

ERCP导管导引线

ERCP套管

竞争分析

波士顿科学公司是ERCP器材市场的全球领导企业。自2015年收购Xlumena及其AXIOS覆膜金属支架以来，该公司在治疗应用领域实现了强劲成长。这些支架专为在超音波内视镜引导下经胃或经十二指肠引流有症状的胰臟假性囊肿和壁坏死而设计。凭藉其广泛的分销网络和成熟的品牌知名度，波士顿科学公司在大多数ERCP产品类别中占据领先地位。

奥林巴斯公司凭藉其V-System短导丝平台已在市场中站稳脚跟，并获得了越来越多转向短导丝平台的医生的支持。儘管进入ERCP市场较晚，奥林巴斯正利用其内视镜产品组合迅速扩大市场份额，尤其是在括约肌切开刀领域。

库克医疗是ERCP领域产品线最丰富的竞争对手之一，提供包括导管导引线、括约肌切开器和体外碎石器在内的全系列产品。库克医疗以其长期稳定的临床合作关係和可靠的设备性能而享有盛誉。括约肌切开器和导管导引线业务的成长进一步巩固了其作为全球领先供应商的地位。

ERCP 市场仍然保持中等集中度，这三家公司占据了全球市场份额的大部分，而其他区域製造商则在特定的细分市场和地区，尤其是在亚太地区和拉丁美洲，占据了一席之地。

科技与临床趋势

短导线系统正逐渐取代长导线技术，进而提高手术控制水平，减少对辅助人员的依赖。

随着医院越来越重视感染预防和工作流程效率，一次性括约肌切开器和插管装置的使用率正在不断提高。

药物释放型支架和管腔黏附支架使得以前需要手术才能进行的先进治疗性介入成为可能。

ERCP手术室中数位影像技术的整合提高了可视化效果和手术准确性。

体外震波碎石设备不断发展，能量传递系统不断改进，缩短了治疗时间，提高了碎石效率。

透过模拟和指导计划扩大培训范围，正在提高全球获得先进 ERCP 手术的机会。

地区

本期内容涵盖北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。

调查方法附录与简称

目录

图表清单

图表列表

调查方法

全球关税的影响

经内视镜逆行性胆胰管摄影术设备市场

• 执行摘要
  • 全球内经内视镜逆行性胆胰管摄影术系统市场概览
  • 竞争分析
  • 流程分段
  • 市场区隔
  • 目标区域
• 介绍
• 手术次数
• 市场概览
  • 按细分市场
  • 按地区
• 市场分析与预测
  • 经内视镜逆行性胆胰管摄影术（ERCP）设备市场整体状况
  • 括约肌切开刀市场
  • 胆结石移除气球市场
  • 胆结石清除篮子市场
  • 胆道扩张球囊市场
  • 胆道和胰管支架市场
  • 胆道碎石机市场
  • ERCP导管导引线市场
  • ERCP套管市场
• 驾驶员和约束装置
• 竞争市占率分析

简称

The global endoscopic retrograde cholangiopancreatography (ERCP) device market was valued at over $1.9 billion in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 5.6%, reaching over $2.8 billion by 2032.

This report covers sphincterotomes, biliary stone removal balloons, biliary stone removal baskets, biliary dilation balloons, biliary and pancreatic stents, biliary lithotripters, ERCP guidewires, and ERCP cannulas.

It quantifies unit sales, average selling prices (ASPs), market values, and growth rates, and includes company shares, market drivers and limiters, recent mergers and acquisitions, and technology trends. The analysis incorporates historical data from 2022 to 2024 and forecasts through 2032.

The scope reflects how healthcare providers are adopting minimally invasive, therapeutic ERCP techniques and how ongoing product innovation, particularly short-wire systems and lumen-apposing stents, is improving procedural efficiency and patient outcomes.

Market Overview

Endoscopic retrograde cholangiopancreatography (ERCP) is a specialized endoscopic procedure used to diagnose and treat conditions of the biliary and pancreatic ducts. It combines endoscopic and fluoroscopic imaging to enable interventions such as sphincterotomy, stone extraction, and stent placement.

Over the past decade, the role of ERCP has evolved from a primarily diagnostic tool to a therapeutic intervention, supported by major advances in device design and procedural technique. This transformation has expanded the addressable market for ERCP devices and positioned the field as a cornerstone of minimally invasive gastrointestinal care.

Market growth is being driven by increasing procedure volumes in both developed and emerging regions. The rising global incidence of biliary obstruction, gallstones, and pancreatitis is fueling demand for ERCP interventions. As populations age and chronic liver diseases become more prevalent, procedure frequency continues to rise.

Technology innovation has been especially impactful in improving physician control and reducing complication rates. The introduction of short-wire systems allows for faster cannulation, enhanced device exchange, and more efficient workflow. These systems are now regarded as the new procedural standard in many high-volume centers.

Drug-eluting and lumen-apposing stent technologies are also expanding the therapeutic capabilities of ERCP, enabling the management of complex indications such as pancreatic fluid collections and walled-off necrosis under endoscopic ultrasound (EUS) guidance.

At the same time, certain segments such as ERCP cannulas are gradually being replaced by more advanced device types like sphincterotomes, limiting growth in specific categories. Despite these internal shifts, the ERCP device market remains positioned for sustained expansion through the next decade, reflecting both strong procedural momentum and the integration of therapeutic endoscopy into routine care.

Market Drivers

Sphincterotome Market

The shift toward therapeutic ERCP is a primary growth driver for the global market. As procedures increasingly focus on intervention rather than diagnosis, sphincterotomes are seeing rising demand. This segment represents one of the largest portions of the ERCP device market and will continue to influence overall growth through 2032.

Advancements in sphincterotome design, such as improved wire control and compatibility with short-wire systems, are further expanding utilization. As hospitals transition toward single-use accessories to reduce infection risk, this category's contribution to overall market value is expected to strengthen.

Short-Wire Systems

The increasing use of short-wire systems is reshaping how ERCP procedures are performed. These systems provide physicians with greater procedural control and efficiency while reducing the need for an assistant during cannulation and device exchange.

Short-wire configurations are more expensive than traditional long-wire systems but offer clinical and operational advantages that justify the premium. Adoption is accelerating in both hospital and ambulatory endoscopy settings, where shorter procedure times improve throughput and reduce anesthesia exposure. As a result, short-wire systems are contributing to rising ASPs and overall revenue growth.

Physician Familiarity and Training

As endoscopists gain more experience and training in therapeutic ERCP, procedural confidence is improving. The rise in physician familiarity has directly translated into higher case volumes per practitioner. Medical societies and device manufacturers are expanding training programs, increasing comfort with advanced ERCP techniques such as sphincterotomy, stenting, and lithotripsy.

These trends are particularly important in emerging markets, where expanded access to training and fluoroscopy equipment is helping to increase the number of qualified providers capable of performing ERCP safely and effectively.

Market Limiters

Cannula Market Decline

The ERCP cannula segment is being steadily replaced by sphincterotome-based techniques. Cannulas once represented a standard access tool but are now losing share as more efficient alternatives become the norm. As a result, unit sales have stagnated and average selling prices have declined for several years. Manufacturers have reduced pricing to remain competitive, suppressing total market value growth.

This structural change is expected to continue until cannulas are fully phased out, reinforcing the dominance of sphincterotome-guided approaches.

Decline in Diagnostic Use of ERCP

The diagnostic application of ERCP has fallen sharply in recent years due to concerns over procedural risk. Diagnostic ERCP carries a small but significant risk of complications, including pancreatitis, infection, and bleeding.

The emergence of non-invasive alternatives such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) has provided clinicians with effective imaging options that avoid these risks. As a result, diagnostic ERCP volumes have declined, shifting utilization toward therapeutic indications.

While this transition supports the growth of therapeutic devices like sphincterotomes and stents, it limits overall procedure expansion and caps market growth potential in some regions.

Price Competition

Competitive pricing pressures are moderating value growth in several ERCP subsegments. In particular, biliary and pancreatic stent markets have seen increasing competition from lower-cost manufacturers in South Korea and China. These suppliers have captured share in cost-sensitive markets such as Europe by offering stents with comparable quality at reduced prices.

Although these pressures are less severe than in other endoscopy markets, they continue to apply downward pressure on ASPs and restrict revenue growth, particularly in the stent and cannula categories.

Market Coverage and Data Scope

Quantitative Coverage

Market size, shares, and forecasts

Growth rates, units sold, and average selling prices

Qualitative Coverage

Market growth trends and limiters

Competitive analysis and SWOT for top competitors

Mergers and acquisitions, company profiles, and product portfolios

FDA recalls and disruptive technology analysis

Disease overview and procedure trends impacting demand

Time Frame

• Base year: 2025
• Forecasts: 2026-2032
• Historical data: 2022-2024

Data Sources

Primary interviews with endoscopists and market executives, regulatory filings, government and hospital data, import and export databases, and iData Research's internal database.

Method Note

Revenue is modeled from units multiplied by ASP, validated with procedural and utilization data and cross-checked with regional replacement and growth assumptions.

Markets Covered and Segmentation

• Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market - Further Segmented Into:

Sphincterotome

Biliary Stone Removal Balloon

Biliary Stone Removal Basket

Biliary Dilation Balloon

Biliary and Pancreatic Stent

Biliary Lithotripter

ERCP Guidewire

ERCP Cannula

Competitive Analysis

Boston Scientific is the dominant global competitor in the ERCP device market. Since acquiring Xlumena and its AXIOS lumen-apposing covered-metal stent in 2015, the company has achieved strong growth in therapeutic applications. These stents are designed for transgastric or transduodenal drainage of symptomatic pancreatic pseudocysts and walled-off necrosis under EUS guidance. Boston Scientific's broad distribution network and established brand recognition support its leadership position across most ERCP product segments.

Olympus Corporation has established a strong foothold through its V-System short-wire platform, which has gained traction among physicians transitioning to short-wire procedures. Although a later entrant into the ERCP market, Olympus has leveraged its endoscopy portfolio to rapidly increase its market share, especially within the sphincterotome category.

Cook Medical remains one of the most diversified competitors in the ERCP space, offering a complete portfolio that includes guidewires, sphincterotomes, and lithotripters. The company benefits from long-standing clinical relationships and a reputation for reliable device performance. Growth within its sphincterotome and guidewire segments continues to reinforce its position as a key global supplier.

The ERCP market remains moderately concentrated, with these three companies controlling a majority of global share. Other regional manufacturers participate in specific niches or geographies, particularly in Asia-Pacific and Latin America.

Technology and Practice Trends

Short-wire systems are replacing long-wire techniques, improving procedural control and reducing reliance on assistant staff.

Single-use sphincterotomes and cannulation devices are gaining adoption as hospitals focus on infection prevention and workflow efficiency.

Drug-eluting and lumen-apposing stents are enabling advanced therapeutic interventions previously requiring surgery.

Digital imaging integration within ERCP suites is enhancing visualization and procedural accuracy.

Lithotripsy devices continue to evolve with improved energy delivery systems that shorten treatment times and improve fragmentation efficiency.

Training expansion through simulation and mentorship programs is increasing global access to advanced ERCP procedures.

Geography

This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global ERCP device market

How will short-wire systems and therapeutic ERCP adoption influence market growth through 2032

What are the key risks and constraints, including price competition and the decline of diagnostic ERCP

Which technological advancements are driving product differentiation in stents, sphincterotomes, and guidewires

How do leading manufacturers Boston Scientific, Olympus, and Cook Medical compete across product categories and regions

What training and infrastructure trends are shaping adoption in emerging markets

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market Report from iData Research answers these questions with procedure-aware models, pricing data, and company share analysis. Use it to quantify demand, support strategic planning, benchmark product performance, and identify future growth opportunities.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Endoscopic Retrograde Cholangiopancreatography Device Market

• 7.1 Executive Summary
  • 7.1.1 Global Endoscopic Retrograde Cholangiopancreatography Device Market Overview
  • 7.1.2 Competitive Analysis
  • 7.1.3 Procedure Segmentation
  • 7.1.4 Market Segmentation
  • 7.1.5 Regions Included
• 7.2 Introduction
• 7.3 Procedure Numbers
• 7.4 Market Overview
  • 7.4.1 By Segment
  • 7.4.2 By Region
• 7.5 Market Analysis And Forecast
  • 7.5.1 Total Endoscopic Retrograde Cholangiopancreatography (Ercp) Device Market
  • 7.5.2 Sphincterotome Market
  • 7.5.3 Biliary Stone Removal Balloon Market
  • 7.5.4 Biliary Stone Removal Basket Market
  • 7.5.5 Biliary Dilation Balloon Market
  • 7.5.6 Biliary And Pancreatic Stent Market
    • 7.5.6.1 Covered-Metal Biliary And Pancreatic Stent Market
    • 7.5.6.2 Bare-Metal Biliary And Pancreatic Stent Market
    • 7.5.6.3 Plastic Biliary And Pancreatic Stent Market
  • 7.5.7 Biliary Lithotripter Market
  • 7.5.8 Ercp Guidewire Market
  • 7.5.9 Ercp Cannula Market
• 7.6 Drivers And Limiters
  • 7.6.1 Market Drivers
  • 7.6.2 Market Limiters
• 7.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 7-1: Endoscopic Retrograde Cholangiopancreatography Device Market, Global, 2025 & 2032
• Chart 7-2: Endoscopic Retrograde Cholangiopancreatography Device Procedures, Global, 2025
• Chart 7-3: ERCP Procedures by Region, Global, 2022 - 2032
• Chart 7-4: Endoscopic Retrograde Cholangiopancreatography Device Market by Segment, Global, 2022 - 2032
• Chart 7-5: Endoscopic Retrograde Cholangiopancreatography Device Market by Region, Global, 2022 - 2032
• Chart 7-6: Leading Competitors, Endoscopic Retrograde Cholangiopancreatography Device Market, Global, 2025

LIST OF FIGURES

• Figure 7-1: Endoscopic Retrograde Cholangiopancreatography Device Procedure Segmentation
• Figure 7-2: Endoscopic Retrograde Cholangiopancreatography Device Market Segmentation
• Figure 7-3: Endoscopic Retrograde Cholangiopancreatography Device Regions Covered, Global (1 of 2)
• Figure 7-4: Endoscopic Retrograde Cholangiopancreatography Device Regions Covered, Global (2 of 2)
• Figure 7-5: ERCP Procedures by Region, Global, 2022 - 2032
• Figure 7-6: ERCP Procedures by Country, North America, 2022 - 2032
• Figure 7-7: ERCP Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 7-8: ERCP Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 7-9: ERCP Procedures by Country, Western Europe, 2022 - 2032
• Figure 7-10: ERCP Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 7-11: ERCP Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 7-12: ERCP Procedures by Country, Middle East, 2022 - 2032
• Figure 7-13: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 7-14: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 7-15: ERCP Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 7-16: ERCP Procedures by Country, Africa, 2022 - 2032
• Figure 7-17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 7-18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 7-19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032
• Figure 7-20: Units Sold by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032
• Figure 7-21: Average Selling Price by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032 (US$)
• Figure 7-22: Market Value by Region, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2022 - 2032 (US$M)
• Figure 7-23: Sphincterotome Market, Global, 2022 - 2032
• Figure 7-24: Units Sold by Region, Sphincterotome Market, Global, 2022 - 2032
• Figure 7-25: Average Selling Price by Region, Sphincterotome Market, Global, 2022 - 2032 (US$)
• Figure 7-26: Market Value by Region, Sphincterotome Market, Global, 2022 - 2032 (US$M)
• Figure 7-27: Biliary Stone Removal Balloon Market, Global, 2022 - 2032
• Figure 7-28: Units Sold by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032
• Figure 7-29: Average Selling Price by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032 (US$)
• Figure 7-30: Market Value by Region, Biliary Stone Removal Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 7-31: Biliary Stone Removal Basket Market, Global, 2022 - 2032
• Figure 7-32: Units Sold by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032
• Figure 7-33: Average Selling Price by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032 (US$)
• Figure 7-34: Market Value by Region, Biliary Stone Removal Basket Market, Global, 2022 - 2032 (US$M)
• Figure 7-35: Biliary Dilation Balloon Market, Global, 2022 - 2032
• Figure 7-36: Units Sold by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032
• Figure 7-37: Average Selling Price by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032(US$)
• Figure 7-38: Market Value by Region, Biliary Dilation Balloon Market, Global, 2022 - 2032 (US$M)
• Figure 7-39: Biliary and Pancreatic Stent Market by Segment, Global, 2022- 2032 (US$M)
• Figure 7-40: Total Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-41: Units Sold by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-42: Average Selling Price by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-43: Market Value by Region, Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-44: Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2031
• Figure 7-45: Units Sold by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-46: Average Selling Price by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-47: Market Value by Region, Covered-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2031 (US$M)
• Figure 7-48: Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-49: Units Sold by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-50: Average Selling Price by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-51: Market Value by Region, Bare-Metal Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-52: Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-53: Units Sold by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032
• Figure 7-54: Average Selling Price by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$)
• Figure 7-55: Market Value by Region, Plastic Biliary and Pancreatic Stent Market, Global, 2022 - 2032 (US$M)
• Figure 7-56: Biliary Lithotripter Market, Global, 2022 - 2032
• Figure 7-57: Units Sold by Region, Biliary Lithotripter Market, Global, 2022 - 2032
• Figure 7-58: Average Selling Price by Region, Biliary Lithotripter Market, Global, 2022 - 2032 (US$)
• Figure 7-59: Market Value by Region, Biliary Lithotripter Market, Global, 2022 - 2031 (US$M)
• Figure 7-60: ERCP Guidewire Market, Global, 2022 - 2032
• Figure 7-61: Units Sold by Region, ERCP Guidewire Market, Global, 2022 - 2032
• Figure 7-62: Average Selling Price by Region, ERCP Guidewire Market, Global, 2022 - 2032 (US$)
• Figure 7-63: Market Value by Region, ERCP Guidewire Market, Global, 2022 - 2032 (US$M)
• Figure 7-64: ERCP Cannula Market, Global, 2022 - 2032
• Figure 7-65: Units Sold by Region, ERCP Cannula Market, Global, 2022 - 2032
• Figure 7-66: Average Selling Price by Region, ERCP Cannula Market, Global, 2022 - 2032 (US$)
• Figure 7-67: Market Value by Region, ERCP Cannula Market, Global, 2022 - 2032 (US$M)
• Figure 7-68: Leading Competitors, Endoscopic Retrograde Cholangiopancreatography (ERCP) Device Market, Global, 2025